🧬 Type IV Hypersensitivity: CD8+ T-Cell–Mediated Cytotoxicity
Type IV hypersensitivity is a T-cell–mediated immune reaction rather than an antibody mediated response. Unlike Types I, II, and III hypersensitivity, antibodies are not the primary drivers. Because the response generally develops over hours to days, Type IV is also called delayed-type hypersensitivity.
🔬 How Do CD8+ T Cells Recognize Target Cells?
CD8+ cytotoxic T lymphocytes recognize intracellular antigens displayed on MHC class I molecules. MHC I is expressed on nearly all nucleated cells and presents peptides derived from proteins inside the cell. The T-cell receptor (TCR) recognizes the antigen–MHC I complex, while the CD8 coreceptor helps stabilize the interaction.
🎯 What Happens After Recognition?
Once appropriately activated, a cytotoxic T cell can bind a target cell displaying its specific antigen. It then delivers signals that initiate apoptosis, allowing the immune system to eliminate infected, abnormal, or otherwise targeted cells while limiting uncontrolled release of intracellular material.
đź’Ą Perforin and Granzyme Pathway
One major killing mechanism involves perforin and granzymes. Perforin helps facilitate granzyme entry into the target cell, and granzymes activate intracellular pathways that lead to programmed cell death. For MCAT purposes, remember the sequence: CD8+ T cell → MHC I recognition → perforin/granzymes → apoptosis.
🔗 Fas–FasL Pathway
CD8+ T cells can also promote apoptosis through the Fas–Fas ligand (FasL) pathway. FasL on the cytotoxic T cell binds Fas on the target cell, activating a death-receptor signaling cascade. This provides another mechanism by which cytotoxic lymphocytes can eliminate target cells.
⏱️ Why Is It Called Delayed Hypersensitivity?
Type IV reactions are described as delayed because they depend on cellular immune responses, including T-cell activation and recruitment, rather than an immediate antibody-driven mechanism. Classic delayed reactions often become apparent around 48–72 hours after antigen exposure.
🧪 CD8+ vs CD4+ Type IV Responses
Type IV hypersensitivity is broader than CD8+ cytotoxicity alone. CD8+ T cells can directly kill target cells, whereas CD4+ T-helper cells can release cytokines that recruit and activate inflammatory cells such as macrophages. Both mechanisms may contribute to T-cell–mediated tissue injury.
| 🧬 Feature | 🛡️ CD8+ T-Cell Response | 🔬 CD4+ T-Cell Response |
|---|---|---|
| Recognition | Antigen on MHC I | Antigen on MHC II |
| Major effect | Direct cytotoxicity | Cytokine-driven inflammation |
| Key mechanisms | Perforin/granzymes, Fas–FasL | Cytokine release, macrophage recruitment |
| Outcome | Target-cell apoptosis | Local inflammation and tissue injury |
đź©ş Important Examples
Examples associated with Type IV hypersensitivity include contact dermatitis, the tuberculin skin test, and some forms of T-cell–mediated tissue injury. The exact immune mechanism varies by condition, so it is useful to distinguish direct CD8+ cytotoxicity from CD4+ cytokine-mediated inflammation.
🧠MCAT High-Yield Takeaway
For the MCAT, associate Type IV = T cells, not antibodies. When the question describes a CD8+ cytotoxic T cell recognizing antigen on MHC I, think of direct target-cell killing through perforin/granzymes or Fas–FasL signaling. This distinction separates Type IV from antibody- and immune-complex–mediated hypersensitivity reactions.
Frequently Asked Questions (FAQs)
-
Aim for 4-6 focused hours, ensuring you incorporate breaks to avoid burnout.
-
Practice mindfulness techniques, take practice exams under realistic conditions, and maintain a balanced lifestyle.
-
Set short-term goals, seek support from mentors, and reward yourself for small achievements.
-
Regular exercise improves focus, reduces stress, and enhances overall mental clarity.
-
KOTC offers personalized learning tools, gamification features, and adaptive question banks to help students stay on track without burnout.